TITLE

Akorn Inc

AUTHOR(S)
Russell, Judi
PUB. DATE
June 1996
SOURCE
New Orleans CityBusiness (1994 to 2008);6/24/96, Vol. 16 Issue 51, p31
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Profiles New Orleans, Louisiana-based Akorn Inc. Company background; Business operations; Financial performance.
ACCESSION #
9607152711

 

Related Articles

  • Late news. Russell, Judi; Delevett, Peter // New Orleans CityBusiness (1994 to 2008);06/09/97, Vol. 17 Issue 49, p1 

    Presents information on different issues relating to business enterprises in the New Orleans, Louisiana area. Akorn Incorporated to move to the Chicago area from Abita Springs; Plans by Alliance for Lower Electric Rates Today to introduce electric competition by January 1999; Stewart...

  • Akorn Inc. Russell, Judi // New Orleans CityBusiness (1994 to 2008);06/23/97, Vol. 17 Issue 51, p32 

    Presents information on the relocation of Akorn Incorporated's sales and administrative headquarters. Description of the company's principal business; Identification of the changed location; When the move is expected to be completed; Background information on the company's division; Comments...

  • Akorn, Inc.  // BioPharm International;Dec2001, Vol. 14 Issue 12, p15 

    Focuses on the pharmaceutical company Akorn Inc. in the United States. Corporate description; Markets of products served by the company; Technical services.

  • FDA approves glaucoma drug.  // Ophthalmology Times;11/6/95, Vol. 20 Issue 43, p34 

    Reports on the US Food and Drug Administration's marketing approval to Akorn Inc.'s eye drop for glaucoma. Trade name and generic name; Akorn's other pending abbreviated new drug applications (ANDA).

  • Investors Relieved? Akorn Stock Retakes 50-Day Line. ALISSA WILLIAMS // Investors Business Daily;3/18/2015, p00 

    The article reports on the big gains of the shares of stocks of pharmaceutical firm Akorn Inc. in the U.S. during the second and third quarter of 2014.

  • AKORN. Investor's Business Daily // Investors Business Daily;3/18/2015, pA02 

    The article reports on the corrections made by specialty drug manufacturer Akorn Inc. for its second quarter (Q2) and third quarter (Q3) revenue for 2014 in the U.S.

  • Applying tiny labels is a challenge. Mans, Jack // Packaging Digest;Sep2002, Vol. 39 Issue 9, p38 

    Features several machine equipment used in the manufacturing process of ampules, syringes and vials from Akorn Inc. in Decatur, Illinois. Function of the Model 6VAK automatic labeler from Newman Machinery; Performance of the EIS 596 product inspection system from Eisai for particulates...

  • Akorn buys drug from allergan.  // Ophthalmology Times;03/01/98, Vol. 23 Issue 5, p19 

    Announces Akorn Inc.'s acquisition of ophthalmic pharmaceutical product Paremyd from Allergen Incorporated. Details of the transaction; Uses of Paremyd.

  • In short...  // Ophthalmology Times;2/15/2003, Vol. 28 Issue 4, p6 

    Reports developments related to ophthalmology as of February 2003. Appointment of John N. Kapoor as chairman of the board for Akorn; Formation of a search committee to locate a replacement for retired Yacha Sutton chief executive officer of Lumenis; Distribution rights of Optikon to market...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics